Max N. Wallace - Director at Humacyte, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Max N. Wallace - trading volume in the past year for Humacyte, Inc.

Holdings reported by Max N. Wallace for Humacyte, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 56,550 $356 K $6.29 May 20, 2024 Direct
Common Stock 3,990 $25.1 K $6.29 May 20, 2024 Max N Wallace IRA
Common Stock 4,015 $24.9 K $6.21 May 20, 2024 Max Wallace SEP IRA
Stock Options (right to buy) 50,000 Jun 13, 2024 Direct Common Stock

Transactions reported by Max N. Wallace for Humacyte, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership